Integra LifeSciences Holdings (IART)
Number of days of payables
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 18.74 | 19.32 | 13.66 | 14.99 | 15.03 | 14.46 | 13.23 | 11.44 | 12.51 | 16.08 | 18.80 | 14.85 | 21.26 | 16.25 | 14.61 | 14.12 | 15.36 | 23.12 | 20.40 | 13.19 | |
Number of days of payables | days | 19.47 | 18.89 | 26.72 | 24.36 | 24.28 | 25.23 | 27.58 | 31.90 | 29.17 | 22.70 | 19.42 | 24.58 | 17.16 | 22.47 | 24.99 | 25.85 | 23.77 | 15.79 | 17.89 | 27.68 |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 18.74
= 19.47
The number of days of payables for Integra LifeSciences Holdings has fluctuated over the past few years, ranging from a low of 15.79 days in September 2020 to a high of 31.90 days in March 2023. As of December 31, 2024, the number of days of payables stands at 19.47 days.
A lower number of days of payables indicates that the company is taking less time to pay its suppliers, which can be beneficial in terms of maintaining good relationships and potentially negotiating better terms. On the other hand, a higher number of days of payables may suggest that the company is taking longer to pay its suppliers, which could signal potential liquidity issues or inefficiencies in managing working capital.
Overall, it is essential for Integra LifeSciences Holdings to closely monitor and manage its number of days of payables to ensure a healthy balance between optimizing cash flow and maintaining positive supplier relationships.
Peer comparison
Dec 31, 2024